rs17222723
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000392.5(ABCC2):c.3563T>A(p.Val1188Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0532 in 1,613,986 control chromosomes in the GnomAD database, including 2,596 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_000392.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ABCC2 | NM_000392.5 | c.3563T>A | p.Val1188Glu | missense_variant | 25/32 | ENST00000647814.1 | NP_000383.2 | |
ABCC2 | XM_006717630.4 | c.2867T>A | p.Val956Glu | missense_variant | 20/27 | XP_006717693.1 | ||
ABCC2 | XM_047424598.1 | c.3563T>A | p.Val1188Glu | missense_variant | 25/26 | XP_047280554.1 | ||
ABCC2 | XR_945604.4 | n.3768T>A | non_coding_transcript_exon_variant | 25/30 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ABCC2 | ENST00000647814.1 | c.3563T>A | p.Val1188Glu | missense_variant | 25/32 | NM_000392.5 | ENSP00000497274 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0539 AC: 8202AN: 152062Hom.: 245 Cov.: 32
GnomAD3 exomes AF: 0.0453 AC: 11386AN: 251494Hom.: 386 AF XY: 0.0457 AC XY: 6213AN XY: 135920
GnomAD4 exome AF: 0.0531 AC: 77680AN: 1461806Hom.: 2347 Cov.: 32 AF XY: 0.0525 AC XY: 38200AN XY: 727210
GnomAD4 genome AF: 0.0540 AC: 8223AN: 152180Hom.: 249 Cov.: 32 AF XY: 0.0523 AC XY: 3891AN XY: 74402
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 10, 2018 | This variant is associated with the following publications: (PMID: 25087612, 18926681, 16628674) - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
ABCC2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 06, 2024 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Dubin-Johnson syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Mar 06, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at